Naiel Nassar, MD

Title(s)Professor, Dean's Office
SchoolSchool of Medicine
AddressLocation Required
Phone559-499-6484
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Naiel N. Nassar, MD, FACP
    Infectious Diseases Division Director/Program Director
    Antibiotic Stewardship Director
    Professor of Clinical Medicine, UCSF

    Naiel Nassar, M.D., specializes in infectious diseases. He is board certified in Internal Disease and Infectious Disease. His fellowship training was completed at the University of California, Davis.

    He was appointed as a faculty member in the Division of Infectious Diseases and the Medical Director of the Center for AIDS Research, Education and Services (CARES) in Sacramento.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. BMC Cancer. 2018 Aug 15; 18(1):822. Saber MM, Al-Mahallawi AM, Nassar NN, Stork B, Shouman SA. PMID: 30111296; PMCID: PMC6094476.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    2. Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice. Neurotoxicology. 2018 07; 67:245-258. Azmy SM, Abd El Fattah MA, Abd El-Rahman SS, Nada SA, Abdel Salam OME, El-Yamany MF, Nassar NN. PMID: 29906478.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    3. Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and/or vitamin E in hyperlipidemic rats. Life Sci. 2018 Jun 15; 203:129-140. Farrag SM, Hamzawy MA, El-Yamany MF, Saad MA, Nassar NN. PMID: 29694831.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    4. Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis. Biochem Pharmacol. 2018 05; 151:126-134. Rabie MA, Abd El Fattah MA, Nassar NN, El-Abhar HS, Abdallah DM. PMID: 29428223.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    5. Nanopyroxene Grafting with β-Cyclodextrin Monomer for Wastewater Applications. ACS Appl Mater Interfaces. 2017 Dec 06; 9(48):42393-42407. Nafie G, Vitale G, Carbognani Ortega L, Nassar NN. PMID: 29112365.
      View in: PubMed   Mentions: 1     Fields:    
    6. Fixed-bed column studies of total organic carbon removal from industrial wastewater by use of diatomite decorated with polyethylenimine-functionalized pyroxene nanoparticles. J Colloid Interface Sci. 2018 Mar 01; 513:28-42. Hethnawi A, Manasrah AD, Vitale G, Nassar NN. PMID: 29132103.
      View in: PubMed   Mentions: 1     Fields:    
    7. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes. JCI Insight. 2017 02 09; 2(3):e89473. Lee LH, Gasilina A, Roychoudhury J, Clark J, McCormack FX, Pressey J, Grimley MS, Lorsbach R, Ali S, Bailey M, Stephens P, Ross JS, Miller VA, Nassar NN, Kumar AR. PMID: 28194436; PMCID: PMC5291734.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    8. The Ying and Yang of Adenosine A1 and A2A Receptors on ERK1/2 Activation in a Rat Model of Global Cerebral Ischemia Reperfusion Injury. Mol Neurobiol. 2018 02; 55(2):1284-1298. Atef RM, Agha AM, Abdel-Rhaman AA, Nassar NN. PMID: 28120151.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    9. Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan; 390(1):61-68. Al-Shorbagy MY, Nassar NN. PMID: 27695956.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    10. The effect of the nanosize on surface properties of NiO nanoparticles for the adsorption of Quinolin-65. Phys Chem Chem Phys. 2016 Mar 07; 18(9):6839-49. Marei NN, Nassar NN, Vitale G. PMID: 26878274.
      View in: PubMed   Mentions: 4     Fields:    
    11. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2016 Mar; 30(3):728-39. Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC. PMID: 26449661; PMCID: PMC4775400.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    12. Maghemite nanosorbcats for methylene blue adsorption and subsequent catalytic thermo-oxidative decomposition: Computational modeling and thermodynamics studies. J Colloid Interface Sci. 2016 Jan 01; 461:396-408. El-Qanni A, Nassar NN, Vitale G, Hassan A. PMID: 26414422.
      View in: PubMed   Mentions: 3     Fields:    
    13. A man with oral lesions, constipation and back pain. Int J STD AIDS. 2014 Jun; 25(7):526-8. Mu A, Nassar N. PMID: 24352119.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    14. Enhanced efficacy and reduced side effects of diazepam by kava combination. J Adv Res. 2014 Sep; 5(5):587-94. Tawfiq RA, Nassar NN, El-Eraky WI, El-Denshary ES. PMID: 25685527; PMCID: PMC4294317.
      View in: PubMed   Mentions: 1     Fields:    
    15. Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study. Int J STD AIDS. 2008 Aug; 19(8):561-2. Keiser PH, Nassar N. PMID: 18663047.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection. Expert Opin Pharmacother. 2007 Mar; 8(4):477-83. Keiser P, Nassar N. PMID: 17309342.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study. HIV Clin Trials. 2003 Sep-Oct; 4(5):358-60. Keiser P, Nassar N, Yazdani B, Armas L, Moreno S. PMID: 14583852.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction. Int J STD AIDS. 2003 Jul; 14(7):478-81. Keiser P, Nassar N, Skiest D, Andrews C, Yazdani B, White A, Hetherington S. PMID: 12869229.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    19. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study. HIV Clin Trials. 2002 Jul-Aug; 3(4):296-303. Keiser P, Nassar N, White C, Koen G, Moreno S. PMID: 12187503.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    20. Trizivir. Expert Opin Pharmacother. 2002 May; 3(5):619-24. Keiser P, Nassar N. PMID: 11996639.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    21. Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts. MMWR Morb Mortal Wkly Rep. 1989 Jun 02; 38(21):369-74. Centers for Disease Control (CDC). PMID: 2497335.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Naiel's Networks
    Concepts (208)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California